Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.intimp.2020.107271 http://scihub22266oqcxt.onion/10.1016/j.intimp.2020.107271 33310664!7724312!33310664     free     free     free Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Int+Immunopharmacol 2021 ; 90 (ä): 107271 Nephropedia Template TP {{tp|p=33310664|t=2021. Persistence of SARS-CoV-2-specific antibodies in COVID-19 patients |pdf=|usr=}}{{33310664}} gab.com Text Persistence of SARS-CoV-2-specific antibodies in COVID-19 patients JO: Int Immunopharmacol http://www.kidney.de/pget.php?&tw=1&pmid=33310664 #FOAvip To better understand humoral immunity following SARS-CoV-2 infection, 114 hospitalised COVID-19 patients with antibody monitored over 8 weeks from symptom onset were retrospectively investigated. A total of 445 serum samples were assessed via chemiluminescence immunoassay. Positive rate of virus-specific IgM reached up to over 80% from the second week to the eighth week after symptom onset, then declined quickly to below 30% in the twelfth week. Concentrations of IgG remained high for at least 3 months before subsequently declining. As compared with the non-severe group, serum IgM level from week 3 to week 8 was significantly higher among the patients with severe clinical symptoms (P = 0.012) but not IgG (P = 0.053). Serum IgM level from week 3 to week 8 was correlated with positive virus RNA test (r = 0.201, P = 0.044), albumin level (r = -0.295, P = 0.003), lactic dehydrogenase (LDH) level (r = 0.292, P = 0.003), alkaline phosphatase (ALP) level (r = 0.254, P = 0.010), C-reactive protein (CRP) level (r = 0.281, P = 0.004) during the same course, while serum IgG level was correlated with age (r = 0.207, P = 0.038). This presented results provide insight into duration of SARS-CoV-2 antibodies and interaction between the virus and host systems. Twit Text FOAVip Persistence of SARS-CoV-2-specific antibodies in COVID-19 patients ????Int Immunopharmacol http://www.kidney.de/pget.php?&tw=1&pmid=33310664 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33310664 #FOAvip English Wikipedia <ref>{{Cite pmid|33310664}}</ref> Persistence of SARS-CoV-2-specific antibodies in COVID-19 patients #MMPMID33310664 Wang Y; Li J; Li H; Lei P; Shen G; Yang C Int Immunopharmacol 2021[Jan]; 90 (ä): 107271 PMID33310664show ga To better understand humoral immunity following SARS-CoV-2 infection, 114 hospitalised COVID-19 patients with antibody monitored over 8 weeks from symptom onset were retrospectively investigated. A total of 445 serum samples were assessed via chemiluminescence immunoassay. Positive rate of virus-specific IgM reached up to over 80% from the second week to the eighth week after symptom onset, then declined quickly to below 30% in the twelfth week. Concentrations of IgG remained high for at least 3 months before subsequently declining. As compared with the non-severe group, serum IgM level from week 3 to week 8 was significantly higher among the patients with severe clinical symptoms (P = 0.012) but not IgG (P = 0.053). Serum IgM level from week 3 to week 8 was correlated with positive virus RNA test (r = 0.201, P = 0.044), albumin level (r = -0.295, P = 0.003), lactic dehydrogenase (LDH) level (r = 0.292, P = 0.003), alkaline phosphatase (ALP) level (r = 0.254, P = 0.010), C-reactive protein (CRP) level (r = 0.281, P = 0.004) during the same course, while serum IgG level was correlated with age (r = 0.207, P = 0.038). This presented results provide insight into duration of SARS-CoV-2 antibodies and interaction between the virus and host systems. |*SARS-CoV-2[MESH] |Aged[MESH] |Antibodies, Viral/*blood[MESH] |C-Reactive Protein/analysis[MESH] |COVID-19/*blood/immunology/virology[MESH] |Female[MESH] |Hospitalization[MESH] |Humans[MESH] |Immunoglobulin G/*blood[MESH] |Immunoglobulin M/*blood[MESH] |L-Lactate Dehydrogenase/blood[MESH] |Male[MESH] |Middle Aged[MESH] |RNA, Viral/analysis[MESH] |Retrospective Studies[MESH] |Serum Albumin/analysis[MESH]Persistence of SARS-CoV-2-specific antibodies in COVID-19 patients (epmc).pdf DeepDyve Pubget Overpricing